Theo D. Michels

发表

Mevalonate analogues as substrates of enzymes in the isoprenoid biosynthetic pathway of Streptococcus pneumoniae.

T. Leyh, Meihao Sun, R. Silverman, 2010, Bioorganic & Medicinal Chemistry.

A synthesis of echinopine B.

C. Vanderwal, Theo D. Michels, M. Dowling, 2012, Angewandte Chemie.

Abstract 2698: eFT226, a potent and selective inhibitor of eIF4A, is efficacious in preclinical models of lymphoma

P. A. Thompson, K. Webster, N. Young, 2019, Experimental and Molecular Therapeutics.

Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A Inhibitors.

P. A. Thompson, P. Sprengeler, S. Reich, 2020, Organic letters.

Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.

P. A. Thompson, K. Webster, N. Young, 2020, Journal of medicinal chemistry.

Synthesis of delta-tributylstannyl-alpha,beta,gamma,delta-unsaturated aldehydes from pyridines.

C. Vanderwal, Theo D. Michels, J. Rhee, 2008, Organic letters.

Synthesis of δ-Tributylstannyl-α,β,γ,δ-Unsaturated Aldehydes from Pyridines

C. Vanderwal, Theo D. Michels, J. Rhee, 2008 .

Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A

P. A. Thompson, K. Webster, N. Young, 2020, Molecular Cancer Therapeutics.

Preclinical Evaluation of eFT226, a Novel, Potent and Selective eIF4A Inhibitor with Anti-Tumor Activity in B-Cell Malignancies

P. A. Thompson, K. Webster, N. Young, 2017 .

Concise formal synthesis of porothramycins A and B via Zincke pyridinium ring-opening/ring-closing cascade.

C. Vanderwal, Theo D. Michels, Matthew J. Kier, 2010, Organic letters.